IRISH JOURNAL OF MEDICAL SCIENCE, cilt.178, sa.2, ss.151-154, 2009 (SCI-Expanded, Scopus)
Beta-2 microglobulin (B2M) has been shown as a marker for monitoring inflammatory disease activity and it appears likely to have a destructive role in amyloidosis-related arthritis. Whether it has a catabolic role in osteoarthritis (OA) remains unclear.